Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | DHODH | Q02127 | 11/20 | 0.39 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.38 |
| ▸ | XDH | P47989 | 1/20 | 0.36 |
| ▸ | GALR1 | P47211 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30046616 | 0.81 | PIM1 (0.39) | DHODHADORA2AADORA1DYRK1A | |
| SCHEMBL20550965 | 0.74 | FFAR1 (0.43) | THRATHRBDHODHADORA2AADORA1 | |
| SCHEMBL29019396 | 0.73 | DHODH (0.44) | THRATHRBDHODHP2RX1XDH | |
| SCHEMBL29441254 | 0.73 | DHODH (0.50) | DHODHXDHGALR1DYRK1A | |
| SCHEMBL24315292 | 0.73 | ADORA1 (0.48) | DHODHADORA2AADORA1XDHGALR1 | |
| SCHEMBL30543216 | 0.73 | GPR3 (0.50) | — | |
| SCHEMBL22229001 | 0.73 | GPR3 (0.50) | — | |
| SCHEMBL22228994 | 0.73 | FFAR4 (0.49) | P2RX1 | |
| SCHEMBL30543206 | 0.73 | FFAR4 (0.49) | P2RX1 | |
| SCHEMBL2090977 | 0.70 | THRA (0.50) | THRATHRBADORA2AADORA1P2RX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492360-B2 | Organic compound and electroluminescent device containing the same | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492360-B2 | Organic compound and electroluminescent device containing the same | OCIAD1, OCIAD2, SLCO4C1 | THRA 4695/4885THRB 4434/4885DHODH 1462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.